1. Home
  2. DEC vs DNA Comparison

DEC vs DNA Comparison

Compare DEC & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diversified Energy Company plc

DEC

Diversified Energy Company plc

SELL

Current Price

$13.61

Market Cap

993.4M

Sector

N/A

ML Signal

SELL

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

SELL

Current Price

$8.71

Market Cap

835.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
DEC
DNA
Founded
2001
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
993.4M
835.7M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
DEC
DNA
Price
$13.61
$8.71
Analyst Decision
Strong Buy
Sell
Analyst Count
10
3
Target Price
★ $20.61
$8.00
AVG Volume (30 Days)
745.2K
★ 2.4M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
★ 8.38%
N/A
EPS Growth
★ 311.06
46.49
EPS
★ N/A
N/A
Revenue
★ $1,829,142,000.00
$170,155,000.00
Revenue This Year
$26.07
N/A
Revenue Next Year
$26.82
$7.59
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 141.54
N/A
52 Week Low
$12.35
$5.37
52 Week High
$18.90
$18.22

Technical Indicators

Market Signals
Indicator
DEC
DNA
Relative Strength Index (RSI) 45.69 42.16
Support Level $12.62 $6.65
Resistance Level $14.32 $10.34
Average True Range (ATR) 0.40 1.49
MACD -0.00 -0.27
Stochastic Oscillator 43.18 0.39

Price Performance

Historical Comparison
DEC
DNA

About DEC Diversified Energy Company plc

Diversified Energy Co engaged in the production, transportation, and marketing of natural gas, NGLs, and oil, managing a diversified portfolio of mature, long-life assets located across the United States. The company derives revenues from the sale of oil, natural gas and natural gas liquids.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: